No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
QA procedures for multimodality preclinical tumor drug response testing
3.J. P. B. O’Connor, A. Jackson, M. Asselin, D. L. Buckley, G. J. M. Parker, and G. C. Jayson, “Quantitative imaging biomarkers in the clinical development of targeted therapeutics: Current and future perspectives,” Lancet Oncol. 9, 766–776 (2008).
4.S. R. Prasad, K. S. Jhaveri, S. Saini, P. F. Hahn, E. F. Halpern, and J. E. Sumner, “CT tumor measurement for therapeutic response assessment: Comparison of unidimensional, bidimensional, and volumetric techniques—Initial observations,” Radiology 225, 416–419 (2002).
5.J. Cortes, J. Rodriguez, J. A. Diaz-Gonzalez, C. Garzon, A. Gurpide, L. Arbea, I. Gill-Bazo, V. Navarro, M. Cambeiro, A. I. Nicolas, S. Martin-Algarra, J. Garcia-Foncillas, and E. Calvo, “Comparison of unidimensional and bidimensional measurement in metastatic non-small cell lung cancer,” Br. J. Cancer 87, 158–160 (2002).
6.J. Park, S. Lee, S. Song, K. Kim, W. Kim, C. Jung, Y. Park, Y. Im, W. Kang, M. Lee, K. Lee, and K. Park, “Measuring response in solid tumors: Comparison of RECIST and WHO response criteria,” Jpn. J. Clin. Oncol. 33, 533–537 (2003).
7.S. Saini, “Radiologic measurement of tumor size in clinical trials: Past, present, and future,” AJR, Am. J. Roentgenol. 176, 333–334 (2001).
8.C. Suzuki, H. Facobsson, T. Hatschek, M. R. Torkzad, K. Boden, Y. Eriksso-Alm, E. Berg, H. Fujii, A. Kubo, and L. Blomqvist, “Radiologic measurements of tumor response to treatment: Practical approaches and limitations,” Radiographics 28, 329–344 (2008).
10.World Health Organization, WHO Handbook for Reporting Results of Cancer Treatment: WHO Offset Publication No. 48 (WHO, Geneva, 1979).
12.P. Therasse, S. G. Arbuck, E. A. Eisenhauer, J. Wanders, R. S. Kapland, L. Rubinstein, J. Verweij, M. V. Glabbeke, A. T. V. Oosterom, M. C. Christian, and S. G. Gwyther, “New guidelines to evaluate the response to treatment in solid tumors,” J. Natl. Cancer Inst. 92, 205–216 (2000).
13.P. K. Julka, D. C. Doval, S. Gupta, and G. K. Rath, “Response assessment in solid tumors: A comparison of WHO, SWOG and RECIST guidelines,” Br. J. Radiol. 81, 444–449 (2008).
14.R. L. Wahl, H. Jacene, Y. Kasamon, and M. A. Lodge, “From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors,” J. Nucl. Med. 50, 122S–150S (2009).
15.K. C. Graham, L. A. Wirtzfeld, L. T. MacKenzie, C. O. Postenka, A. C. Groom, I. C. MacDonald, A. Fenster, J. C. Lacefield, and A. F. Chambers, “Three-dimensional high-frequency ultrasound for longitudinal evaluation of liver metastases in preclinical models,” Cancer Res. 65, 5231–5237 (2005).
16.I. C. Girit, M. Jure-Kunke, and K. W. McIntyre, “A structured light-based system for scanning subcutaneous tumors in laboratory animals,” Comp. Med. 58, 264–270 (2008).
17.T. Ishimori, M. Tatsumi, and R. L. Wahl, “Tumor response assessment is more robust with sequential CT scanning than external caliper measurements,” Acad. Radiol. 12, 776–781 (2005).
19.C. S. Snyder, S. Kaushal, Y. Kono, H. T. Cao, R. M. Hoffman, and M. Bouvet, “Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer,” BMC Cancer 9, 106 (2009).
20.L. Martiniova, M. S. Kotys, D. Thomasson, D. Schimel, E. W. Lai, M. Bernardo, M. J. Merino, J. F. Powers, J. Ruzicka, R. Kvetnansky, P. L. Choyke, and K. Pacak, “Non-invasive monitoring of a murine model of metastatic pheochromocytoma: A comparison of contrast enhanced microCT and non-enhanced MRI,” J. Magn. Reson Imaging 29, 685–691 (2009).
21.S. M. Weber, K. A. Peterson, B. Durkee, C. Qi, M. Longino, T. Warner, F. T. Lee, and J. P. Weichert, “Imaging of murine liver tumor using MICROCT with a hepatocyto-selective contrast agent: Accuracy is dependent on adequate contrast enhancement,” J. Surg. Res. 119, 41–45 (2004).
22.M. M. Jensen, J. T. Joergensen, T. Binderup, and A. Kjaer, “Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper,” BMC Medical Imaging 8, 16 (2008).
23.S. R. Cherry et al., “MicroPET: A high resolution PET scanner for imaging small animals,” IEEE Trans. Nucl. Sci. 44, 1161–1166 (1997).
27.S. R. Meikle, P. Kench, M. Kassiou, and R. B. Banati, “Small animal SPECT and its place in the matrix of molecular imaging technologies,” Phys. Med. Biol. 50, R45–R61 (2005).
29.L. Ollivier, J. Leclère, P. Thiesse, D. D. Stefano, and C. Vincent, “Measurement of tumour response to cancer treatment: Morphologic imaging role,” Bull. Cancer 94, 171–177 (2007).
30.W. D. D’Souza, E. L. Madsen, O. Unal, K. K. Vigen, G. R. Frank, and B. R. Thomadsen, “Tissue mimicking materials for a multi-imaging modality prostate phantom,” Med. Phys. 28, 688–700 (2001).
32.M. M. Tomayko and C. P. Reynolds, “Determination of subcutaneous tumor size in athymic (nude) mice,” Cancer Chemother. Pharmacol. 24, 148–154 (1989).
33.A. S. Smith, M. A. Weinstein, M. T. Modic, W. Pavlicek, L. R. Rogers, T. G. Budd, R. M. Bukowski, J. D. Purvis, J. K. Weick, and P. M. Duchesneau, “Magnetic resonance with marked T2-weighted images: Improved demonstration of brain lesions, tumor, and edema,” AJR, Am. J. Roentgenol. 145, 949–955 (1985).
34.R. B. Dietrich, R. B. Lufkin, H. Kangarloo, W. N. Hanafee, and G. H. Wilson, “Head and neck MR imaging in the pediatric patient,” Radiology 159, 769–776 (1986).
35.J. P. Petasnick, D. A. Turner, J. R. Charters, S. Gitelis, and C. E. Zacharias, “Soft-tissue masses of the locomotor system comparison of MR imaging with CT,” Radiology 160, 125–133 (1986).
36.P. A. Kaplan and S. M. Williams, “Mucocutaneous and peripheral soft-tissue hemangiomas: MR imaging,” Radiology 163, 163–166 (1987).
39.M. Markl, R. Bammer, M. T. Alley, C. J. Elkins, M. T. Draney, A. Barnett, M. E. Moseley, G. H. Glover, and N. J. Pelc, “Generalized reconstruction of phase contrast MRI: Analysis and correction of the effect of gradient field distortions,” Magn. Reson. Med. 50(4), 791–801 (2003).
40.J. M. Peeters, C. Bos, and C. J. G. Bakker, “Analysis and correction of gradient nonlinearity and inhomogeneity related scaling errors in two-dimensional phase contrast flow measurements,” Magn. Reson. Med. 53, 126–133 (2005).
41.T. Truong, D. W. Chakeres, D. Q. Beversdorf, D. W. Scharre, and P. Schmalbrock, “Effects of static and radiofrequency magnetic field inhomogeneity in ultra-high magnetic resonance imaging,” Magn. Reson. Imaging 24, 103–112 (2006).
Article metrics loading...
Full text loading...
Most read this month